SANTOPIETRO, MICHELINA
 Distribuzione geografica
Continente #
NA - Nord America 870
EU - Europa 323
AS - Asia 112
AF - Africa 21
SA - Sud America 4
OC - Oceania 1
Totale 1.331
Nazione #
US - Stati Uniti d'America 850
IT - Italia 117
SE - Svezia 101
IN - India 51
CN - Cina 38
GB - Regno Unito 21
CA - Canada 20
TG - Togo 20
DE - Germania 16
BG - Bulgaria 15
RO - Romania 15
SG - Singapore 15
IE - Irlanda 10
FI - Finlandia 7
ES - Italia 6
UA - Ucraina 5
TR - Turchia 4
AL - Albania 2
AR - Argentina 2
CH - Svizzera 2
HK - Hong Kong 2
SI - Slovenia 2
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
FR - Francia 1
IL - Israele 1
IR - Iran 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.331
Città #
Fairfield 149
Chandler 101
Seattle 51
Woodbridge 51
Houston 48
Ashburn 44
Cambridge 41
Wilmington 38
Rome 37
Princeton 28
Plano 24
Beijing 22
Millbury 22
Lawrence 20
Lomé 20
San Paolo di Civitate 17
New York 15
Sofia 15
Andover 13
Ann Arbor 12
San Diego 12
Ottawa 11
Bremen 10
Dublin 9
Toronto 9
Atella 8
Carmarthen 8
Dearborn 8
Bari 7
Boston 7
Des Moines 7
Norwalk 7
Phoenix 6
Singapore 6
Hefei 5
Helsinki 4
Madrid 4
Southend 4
Timisoara 4
Brookline 3
Cattolica 3
Fonte Nuova 3
Pavia 3
Pune 3
Ankara 2
Barcelona 2
Bologna 2
Buffalo 2
Bühl 2
Chennai 2
Federal 2
Fremont 2
Hong Kong 2
Istanbul 2
Ljubljana 2
Marly 2
Melrose 2
Monopoli 2
Muswell Hill 2
Redmond 2
Rimini 2
San Mateo 2
Sant'Anastasia 2
Tirana 2
Turin 2
Watertown 2
Azor 1
Baotou 1
Berlin 1
Besana In Brianza 1
Boydton 1
Brasília 1
Bratislava 1
Brussels 1
Cairo 1
Chaoyang 1
Chengdu 1
Cormeilles-en-Parisis 1
Edinburgh 1
Falls Church 1
Haverfordwest 1
Hebei 1
Hunedoara 1
Jinan 1
Kunming 1
London 1
Los Angeles 1
Milan 1
Nanning 1
Naples 1
Padova 1
Piemonte 1
Provo 1
Rotterdam 1
Santiago 1
Shaoxing 1
Shenyang 1
Southwark 1
St. Cloud 1
Trento 1
Totale 997
Nome #
A case of motor neuron involvement in Gaucher disease 87
Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia 79
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib 78
Atypical chronic myeloid leukemia in a patient with aplastic anemia 78
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience 75
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience 72
The different dermoscopic features of the yellow background in Langerhans and non-Langerhans cells histiocytosis 69
Suboptimal response to imatinib according to 2006-2009 European LeukaemiaNet criteria: A 'grey zone' at 3, 6 and 12 months identifies chronic myeloid leukaemia patients who need early intervention 63
Intermittent Imatinib mesylate in children with chronic myeloid leukemia: results and outcome 56
INDOMETHACIN AS FIRST LINE TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS (LCH). A 20-YEAR EXPERIENCE OF A SINGLE CENTRE. 56
Management of Chronic Myeloid Leukemia in children and adolescents according to local guidelines the Italian experience 55
Multiple granuloma faciale: A clinical finding from a dermoscopic point a view 54
EFFICACIA E SICUREZZA DELL’IMPIEGO DEI PICC IN PAZIENTI PEDIATRICI AFFETTI DA LEUCEMIA ACUTA: ESPERIENZA MONOCENTRICA 54
Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 51
Mast cell disorders, melanoma and pancreatic carcinoma: from a clinical observation to a brief review of the literature 50
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis 50
Next-Generation Sequencing (NGS) in childhood Myeloproliferative Diseases (MPD) 48
Applicazione della classificazione WHO 2016 IN 80 bambini e adolescenti con neoplasie mieloproliferative croniche 45
EFFICACY OF INDOMETHACIN AS SALVAGE THERAPY IN CHILDREN AND ADULTS WITH LANGERHANS CELL HISTIOCYTOSIS WITH BONE INVOLVEMENT 40
UTILITA’ DELLA TECNICA NEXT GENERATION SEQUENCING (NGS) NELL’IDENTIFICAZIONE DI GENI NON-DRIVER IN PAZIENTI CON MALATTIE MIELOPROLIFERATIVE CRONICHE (MMC) PEDIATRICHE WILD TYPE: ESPERIENZA DI UN SINGOLO CENTRO 39
Managing Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 38
Clinical features and therapeutic results in a 35-year cohort of children and adults with Langerhans cell histiocytosis managed at a single institution. 36
Iron deficiency in children and adolescents: an alarm bell for gastrointestinal diseases. 33
Long-term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. The Italian Experience. 33
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms 31
Abstracts from the 36th Annual Meeting of the Histiocyte Society Virtual Sessions: October 1, 2020 and November 5, 2020 30
WHO 2016 classification in 80 children and adolescents with chronic myeloproliferative neoplasms 22
Sequential occurrence of chronic myeloproliferative and lymphoproliferative neoplasms. a collaborative retrospective study by pH-negative MPN latial group 18
Genetic screening of children with marrow failure. The role of primary Immunodeficiencies 17
Gruppi sanguigni e terapia trasfusionale 9
null 6
Totale 1.472
Categoria #
all - tutte 3.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019112 0 0 0 0 0 0 0 0 0 0 22 90
2019/2020308 37 7 0 14 39 41 38 38 37 23 12 22
2020/2021111 11 13 11 0 8 5 4 10 21 3 11 14
2021/2022275 21 14 14 19 42 19 6 20 14 18 40 48
2022/2023410 69 75 21 50 40 41 8 18 53 5 16 14
2023/2024182 27 28 15 12 29 27 3 16 6 19 0 0
Totale 1.472